Newly Diagnosed?
GCS Resources
Connect with a Physician
Community Forums

What is Gynecological Carcinosarcoma?

Gynecological Carcinosarcoma (GCS) is a rare and aggressive cancer found primarily in the ovaries and uterus and can also originate in the fallopian tubes and vagina. GCS, is also known as MMMT or malignant mixed Müllerian tumor. Carcinosarcoma is unique in that it contains two types of cells; carcinomatous (epithelial tissue) and sarcomatous (connective tissue). GCS is rare. Fewer than 1,000 cases of GCS are diagnosed each year. Because carcinosarcoma is so rare, there has been limited research or clinical trials that focus on GCS. Unfortunately, this is where the cures will be found. Little or no research results in no cures or effective treatments for us. In order for us to have a fighting chance, we must aggressively support new and ongoing research so that Not One More Woman Will Die from this rotten cancer.

Sign Up for Updates

Register to the GCS Cancer Project for important updates on our research, clinical trials and latest news.

Register Here

Get Involved

Join this amazing community providing hope, answers, resources & support!
Register
Raise Awareness
Help Build Our Experts Knowledge Base

GCS News

The latest news and most engaged discussions from our website.
ANNOUNCING — VIDEO CONSULTATION WITH A GCS SPECIALIST!

We are excited to announce that we have made arrangements through a third party — InfiniteMD — that will allow patients to schedule video consultations for a second opinion with Dr. Michael Birrer If you have reviewed our website and listened to our videos from experts, you know that we strongly support seeking a second […]

Diane Redington passed away on March 15, 2018 – but her legacy and the GCS Project lives on.

Diane (Dede) Redington, the beloved, inspirational founder of the GCS Project — dedicated to finding a cure for gynecological carsinosarcoma or MMMT — passed away on March 15, 2018. To honor Diane’s valiant three-year battle and tireless efforts to find a cure for this rare, insidious disease, the GCS Project will continue to support her […]

GCS has applied for a 501c3 IRS Designation

The GCS Project has filed with the IRS to become a 501c3. As per the IRS letter, we expect to receive our approval letter by December 1, 2017. Any donation made to the GCS Project during this application period will be tax deductible.   Obtaining 501c3 status will enable the GCS Project to become eligible […]

View More